CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $613,506
- in 6 filings
Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-18 | Murphy Brian Stuart CEO, Chief Medical Officer | Grant or award | +900,000 | 1,275,000 | ||
| 2018-01-18 | LYKOS COSMAS N Chairman | Grant or award | +900,000 | 4,599,400 | ||
| 2018-01-18 | Berecz Elizabeth Chief Financial Officer | Grant or award | +700,000 | 1,050,000 | ||
| 2017-03-13 | Lapham Reg Alexander 10% owner | Option exercise | −119,700 | $1.00 | $120K | 3,787,500 |
| 2015-10-20 | INGRAM DOUGLAS S Vice Chairman | Grant or award | +60,000 | 372,500 | ||
| 2015-10-20 | McLaughlin Gerald W. Director | Grant or award | +30,000 | 61,250 | ||
| 2015-10-20 | GEORGE THOMAS Director | Grant or award | +60,000 | 60,000 | ||
| 2015-10-20 | LYKOS COSMAS N Chairman | Grant or award | +325,000 | 3,699,400 | ||
| 2015-10-20 | Berecz Elizabeth Chief Financial Officer | Grant or award | +350,000 | 350,000 | ||
| 2015-10-20 | Murphy Brian Stuart CEO, Chief Medical Officer | Grant or award | +375,000 | 375,000 | ||
| 2015-08-20 | INGRAM DOUGLAS S Vice Chairman | Conversion | +312,500 | 312,500 | ||
| 2015-08-20 | INGRAM DOUGLAS S Vice Chairman | Conversion · Series A Preferred Stock | −100,000 | 0 | ||
| 2015-08-20 | McLaughlin Gerald W. Director | Conversion | +31,250 | 31,250 | ||
| 2015-08-20 | McLaughlin Gerald W. Director | Conversion · Series A Preferred Stock | −10,000 | 0 | ||
| 2015-06-01 | INGRAM DOUGLAS S Vice Chairman | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2015-05-29 | McLaughlin Gerald W. Director | Purchase · Series A Preferred Stock | +10,000 | $2.50 | $25K | 10,000 |
| 2015-05-29 | McLaughlin Gerald W. Director | Purchase · Common Stock Warrant (Right to Buy) | +2,000 | 2,000 | ||
| 2015-04-10 | Ladin Brian D 10% owner | Sale | −11,830 | $4.93 | $58K | 249,098 |
| 2015-04-08 | Ladin Brian D 10% owner | Sale | −23,000 | $4.69 | $108K | 276,728 |
| 2015-04-08 | Ladin Brian D 10% owner | Sale | −15,800 | $4.79 | $76K | 260,928 |
Page 14 of 15 · 292 trades